Table 1.
Baseline Characteristics of the Completed Study Participants
| Characteristic | SAP (n = 21) | USS Virginia HCLC (n = 21) |
|---|---|---|
| Male (%) | 28.6 | 52.4 |
| CGM users' pretrial (%) | 66.7 | 71.4 |
| Age (years)a | 38.0 ± 3.3 | 38.3 ± 3.3 |
| Duration of diabetes (years)a | 18.2 ± 2.3 | 21.2 ± 2.6 |
| BMIa,b | 27.0 ± 1.0 | 26.0 ± 1.2 |
| Total daily insulin (units)a | 43.7 ± 3.6 | 49.0 ± 4.8 |
| BG for low symptoms mg/dL (mmol/L) | 54.77 ± 2.22 (3.03 ± 0.13) | 50.68 ± 1.45 (2.84 ± 0.08) |
| LBGI from baseline CGMa | 2.1 ± 0.23 | 2.51 ± 0.26 |
| Clarke scorea | 3.19 ± 0.28 | 3.81 ± 0.32 |
| Screening HbA1c% (mmol/mol)a | 7.5 ± 0.2 (59 ± 1.5) | 7.2 ± 0.2 (55 ± 1.5) |
a
Mean ± SD.
b
BMI is weight in kilograms divided by height in meters squared.
BG, blood glucose; BMI, body mass index; CGM, continuous glucose monitoring; HbA1c, hemoglobin A1c; LBGI, Low Blood Glucose Index; SAP, sensor-augmented pump; SD, standard deviation.